155 related articles for article (PubMed ID: 38345077)
1. External Validation of the International Prognosis Prediction Model of IgA Nephropathy.
Hu L; Fang Y; Huang J; Liu J; Xu L; He W
Ren Fail; 2024 Dec; 46(1):2313174. PubMed ID: 38345077
[TBL] [Abstract][Full Text] [Related]
2. External Validation of the International IgA Nephropathy Prediction Tool.
Zhang J; Huang B; Liu Z; Wang X; Xie M; Guo R; Wang Y; Yu D; Wang P; Zhu Y; Ren J
Clin J Am Soc Nephrol; 2020 Aug; 15(8):1112-1120. PubMed ID: 32616496
[TBL] [Abstract][Full Text] [Related]
3. Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up.
Haaskjold YL; Lura NG; Bjørneklett R; Bostad L; Bostad LS; Knoop T
Nephrol Dial Transplant; 2023 May; 38(5):1183-1191. PubMed ID: 35904322
[TBL] [Abstract][Full Text] [Related]
4. External validation of the pediatric International IgA Nephropathy Prediction Tool in a central China cohort.
Ying D; Lu M; Zhi Y; Shi P; Cao L; Wang Q; Zhang Y; Zhang J
Clin Exp Nephrol; 2024 Jan; 28(1):59-66. PubMed ID: 37713045
[TBL] [Abstract][Full Text] [Related]
5. Validation of the international IgA nephropathy prediction tool in a French cohort beyond 10 years after diagnosis.
Bon G; Jullien P; Masson I; Sauron C; Dinic M; Claisse G; Pelaez A; Thibaudin D; Mohey H; Alamartine E; Mariat C; Maillard N
Nephrol Dial Transplant; 2023 Sep; 38(10):2257-2265. PubMed ID: 37316441
[TBL] [Abstract][Full Text] [Related]
6. External Validation of the International IgA Nephropathy Prediction Tool in Older Adult Patients.
Zhang Q; Zhang Q; Duan Z; Chen P; Chen JJ; Li MX; Zhang JJ; Huo YH; Zhang WX; Yang C; Zhang Y; Chen X; Cai G
Clin Interv Aging; 2024; 19():911-922. PubMed ID: 38799377
[TBL] [Abstract][Full Text] [Related]
7. Renal Interstitial Inflammation Predicts Nephropathy Progression in IgA Nephropathy: A Two-Center Cohort Study.
Zhu B; Liu WH; Lin Y; Li Q; Yu DR; Jiang F; Tang XL; Du YY; Yin JZ; Li XF; Zhong YZ; Wang WR; Sun Y; Zhang MJ; Gao YC; Yuan CY; Zhu CF; Cheng XX
Am J Nephrol; 2022; 53(6):455-469. PubMed ID: 35576899
[TBL] [Abstract][Full Text] [Related]
8. Prediction of ESRD in IgA Nephropathy Patients from an Asian Cohort: A Random Forest Model.
Liu Y; Zhang Y; Liu D; Tan X; Tang X; Zhang F; Xia M; Chen G; He L; Zhou L; Zhu X; Liu H
Kidney Blood Press Res; 2018; 43(6):1852-1864. PubMed ID: 30537719
[TBL] [Abstract][Full Text] [Related]
9. A Validation Study Comparing Risk Prediction Models of IgA Nephropathy.
Ouyang Y; Zhao Z; Li G; Luo H; Xu F; Shao L; Chen Z; Yu S; Jin Y; Xu J; Shi M; Hussain HMJ; Du W; Fang Z; Pan X; Wang W; Xie J; Chen N
Front Immunol; 2021; 12():753901. PubMed ID: 34721428
[TBL] [Abstract][Full Text] [Related]
10. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
Knoop T; Vågane AM; Vikse BE; Svarstad E; Magnúsdóttir BT; Leh S; Varberg Reisæter A; Bjørneklett R
Am J Nephrol; 2015; 41(3):210-9. PubMed ID: 25872002
[TBL] [Abstract][Full Text] [Related]
11. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H
Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
Tian S; Yang X; Luo J; Guo H
Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
[TBL] [Abstract][Full Text] [Related]
13. Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients.
Xie J; Lv J; Wang W; Li G; Liu Z; Chen H; Xu F; Sun J; Ouyang Y; Zhang X; Yang M; Shi M; Zhang W; Ren H; Kiryluk K; Zhang H; Chen N
Am J Kidney Dis; 2018 Sep; 72(3):371-380. PubMed ID: 29555434
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.
Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Tsuchimoto A; Noguchi H; Hirakata H; Tsuruya K; Kitazono T
Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970
[TBL] [Abstract][Full Text] [Related]
15. The MEST score provides earlier risk prediction in lgA nephropathy.
Barbour SJ; Espino-Hernandez G; Reich HN; Coppo R; Roberts IS; Feehally J; Herzenberg AM; Cattran DC; ;
Kidney Int; 2016 Jan; 89(1):167-75. PubMed ID: 26759049
[TBL] [Abstract][Full Text] [Related]
16. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
17. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
Chai L; Cai K; Wang K; Luo Q
J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
[TBL] [Abstract][Full Text] [Related]
18. Positive renal familial history in IgA nephropathy is associated with worse renal outcomes: a single-center longitudinal study.
Sato Y; Tsukaguchi H; Higasa K; Kawata N; Inui K; Linh TNT; Quynh TTH; Yoshihiko I; Koiwa F; Yoshimura A
BMC Nephrol; 2021 Jun; 22(1):230. PubMed ID: 34147067
[TBL] [Abstract][Full Text] [Related]
19. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S; Li JP
Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
[TBL] [Abstract][Full Text] [Related]
20. Updating the International IgA Nephropathy Prediction Tool for use in children.
Barbour SJ; Coppo R; Er L; Russo ML; Liu ZH; Ding J; Katafuchi R; Yoshikawa N; Xu H; Kagami S; Yuzawa Y; Emma F; Cambier A; Peruzzi L; Wyatt RJ; Cattran DC;
Kidney Int; 2021 Jun; 99(6):1439-1450. PubMed ID: 33220356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
